Marianne Mazevet
Overview
Explore the profile of Marianne Mazevet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazevet M, Oberli C, Marinelli S, Zaed I, Bauer S, Kaelin-Lang A, et al.
Front Oncol
. 2024 May;
14:1361022.
PMID: 38741783
Purpose: Glioblastoma is the most common type of primary brain malignancy and has a poor prognosis. The standard treatment strategy is based on maximal safe surgical resection followed by radiotherapy...
2.
Igarashi T, Mazevet M, Yasuhara T, Yano K, Mochizuki A, Nishino M, et al.
Nat Commun
. 2023 Aug;
14(1):4991.
PMID: 37591859
Activation of the KRAS oncogene is a source of replication stress, but how this stress is generated and how it is tolerated by cancer cells remain poorly understood. Here we...
3.
Mazevet M, Belhadef A, Ribeiro M, Dayde D, Llach A, Laudette M, et al.
Elife
. 2023 Aug;
12.
PMID: 37551870
Anthracyclines, such as doxorubicin (Dox), are widely used chemotherapeutic agents for the treatment of solid tumors and hematologic malignancies. However, they frequently induce cardiotoxicity leading to dilated cardiomyopathy and heart...
4.
Kurashima K, Kashiwagi H, Shimomura I, Suzuki A, Takeshita F, Mazevet M, et al.
NAR Cancer
. 2021 Jul;
2(2):zcaa005.
PMID: 34316685
The SWI/SNF chromatin remodeling complex regulates transcription through the control of chromatin structure and is increasingly thought to play an important role in human cancer. Lung adenocarcinoma (LADC) patients frequently...
5.
Llach A, Mazevet M, Mateo P, Villejouvert O, Ridoux A, Rucker-Martin C, et al.
J Mol Cell Cardiol
. 2018 Dec;
126:129-139.
PMID: 30500377
Cardiac failure is a common complication in cancer survivors treated with anthracyclines. Here we followed up cardiac function and excitation-contraction (EC) coupling in an in vivo doxorubicin (Dox) treated mice...
6.
Monceau V, Llach A, Azria D, Bridier A, Petit B, Mazevet M, et al.
Radiother Oncol
. 2014 Apr;
111(1):63-71.
PMID: 24721545
Background: Cardiac toxicity is a side-effect of anti-cancer treatment including radiotherapy and this translational study was initiated to characterize radiation-induced cardiac side effects in a population of breast cancer patients...
7.
Chargari C, Riet F, Mazevet M, Morel E, Lepechoux C, Deutsch E
Presse Med
. 2013 Aug;
42(9 Pt 2):e342-51.
PMID: 23972736
The issue of toxicity is a primary concern for chest irradiation, because it is a dose-limiting toxicity and because in some circumstances it can alleviate the survival benefit of radiation...
8.
Mazevet M, Moulin M, Llach-Martinez A, Chargari C, Deutsch E, Gomez A, et al.
Presse Med
. 2013 Aug;
42(9 Pt 2):e352-61.
PMID: 23972551
Anthracyclines, discovered 50 years ago, are antibiotics widely used as antineoplastic agents and are among the most successful anticancer therapies ever developed to treat a wide range of cancers, including...